Abstract
This study examined optimal guidelines to assess treatment response and remission for anxiety in youth with autism spectrum disorders (ASD) using the Pediatric Anxiety Rating Scale (PARS). Data was collected for 108 children aged 7–16 years with comorbid anxiety and ASD before and after receiving cognitive behavior therapy. Optimal cut-offs on the PARS were assessed using signal detection analyses using receiver operating characteristic methods. Maximum agreement with response criteria was achieved at 15 % reduction in symptoms on the PARS. Maximum agreement with remission criteria was achieved at 40 % reduction in symptoms, or at a score of 10 or below at post-treatment. Results have implications for standardizing criteria used in research trials and clinical practice.
Similar content being viewed by others
References
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th ed.). Washington, DC: Author.
Bandelow, B. (2006). Defining response and remission in anxiety disorders: Toward an integrated approach. CNS Spectrums, 11(10 Suppl 12), 21–28.
Caporino, N. E., Brodman, D. M., Kendall, P. C., Albano, A. M., Sherrill, J., Piacentini, J., et al. (2013). Defining treatment response and remission in child anxiety: Signal detection analysis using the Pediatric Anxiety Rating Scale. Journal of the American Academy of Child and Adolescent Psychiatry, 52(1), 57–67.
Chalfant, A. M., Rapee, R. M., & Carroll, L. (2007). Treating anxiety disorders in children with high functioning autism spectrum disorders: A controlled trial. Journal of Autism and Developmental Disorders, 37(10), 1842–1857. doi:10.1007/s10803-006-0318-4.
Ehrenreich-May, J., Storch, E. A., Queen, A. H., Hernandez Rodriguez, J., Ghilain, C. S., Alessandri, M., et al. (2014). An open trial of cognitive-behavioral therapy for anxiety disorders in adolescents with autism spectrum disorders. Focus on Autism and Other Developmental Disabilities, 29(3), 145–155. doi:10.1177/1088357614533381.
Farris, S. G., McLean, C. P., Van Meter, P. E., Simpson, H. B., & Foa, E. B. (2013). Treatment response, symptom remission, and wellness in obsessive–compulsive disorder. Journal of Clinical Psychiatry, 74(7), 685–690. doi:10.4088/JCP.12m07789.
Ginsburg, G. S., Keeton, C. P., Drazdowski, T. K., & Riddle, M. A. (2011). The utility of clinicians ratings of anxiety using the Pediatric Anxiety Rating Scale (PARS). Child & Youth Care Forum, 40(2), 93–105. doi:10.1007/s10566-010-9125-3.
Guy, W. (1976). Clinical global impressions ECDEU assessment manual for psychopharmacology. Rockville, MD: National Institute for Mental Health.
Jeon, S., Walkup, J. T., Woods, D. W., Peterson, A., Piacentini, J., Wilhelm, S., et al. (2013). Detecting a clinically meaningful change in tic severity in Tourette syndrome: A comparison of three methods. Contemporary Clinical Trials, 36(2), 414–420. doi:10.1016/j.cct.2013.08.012.
Kerns, C. M., & Kendall, P. C. (2012). The presentation and classification of anxiety in autism spectrum disorder. Clinical Psychology: Science and Practice, 19(4), 323–347. doi:10.1111/cpsp.12009.
Kerns, C. M., Kendall, P. C., Berry, L., Souders, M. C., Franklin, M. E., Schultz, R. T., et al. (2014). Traditional and atypical presentations of anxiety in youth with autism spectrum disorder. Journal of Autism and Developmental Disorders, 44(11), 2851–2861. doi:10.1007/s10803-014-2141-7.
Kerns, C. M., Maddox, B. B., Kendall, P. C., Rump, K., Berry, L., Schultz, R. T., et al. (2015). Brief measures of anxiety in non-treatment-seeking youth with autism spectrum disorder. Autism,. doi:10.1177/1362361314558465.
Kraemer, H. C., Kupfer, D. J., Clarke, D. E., Narrow, W. E., & Regier, D. A. (2012). DSM-5: How reliable is reliable enough? American Journal of Psychiatry, 169(1), 13–15. doi:10.1176/appi.ajp.2011.11010050.
Kraemer, H. C., Periyakoil, V. S., & Noda, A. (2002). Kappa coefficients in medical research. Statistics in Medicine, 21(14), 2109–2129. doi:10.1002/sim.1180.
Leckman, J. F., Riddle, M. A., Hardin, M. T., Ort, S. I., Swartz, K. L., Stevenson, J., et al. (1989). The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. Journal of the American Academy of Child and Adolescent Psychiatry, 28(4), 566–573. doi:10.1097/00004583-198907000-00015.
Lewin, A. B., De Nadai, A. S., Park, J. M., Goodman, W. K., Murphy, T. K., & Storch, E. A. (2011). Refining clinical judgment of treatment outcome in obsessive–compulsive disorder. Psychiatry Research, 185, 394–401.
Lewin, A. B., & Storch, E. A. (2014). Unpublished data.
Lord, C., Rutter, M., DiLavore, P. C., & Risi, S. (1999). Autism diagnostic observation schedule. Los Angeles: Western Psychological Services.
Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24(5), 659–685.
McNally Keehn, R. H., Lincoln, A. J., Brown, M. Z., & Chavira, D. A. (2013). The coping cat program for children with anxiety and autism spectrum disorder: A pilot randomized controlled trial. Journal of Autism and Developmental Disorders, 43(1), 57–67. doi:10.1007/s10803-012-1541-9.
Reaven, J. A., Blakeley-Smith, A., Culhane-Shelburne, K., & Hepburn, S. (2012). Group cognitive behavior therapy for children with high-functioning autism spectrum disorders and anxiety: A randomized trial. Journal of Child Psychology and Psychiatry, 53(4), 410–419. doi:10.1111/j.1469-7610.2011.02486.x.
Rudy, B. M., Lewin, A. B., & Storch, E. A. (2013). Managing anxiety comorbidity in youth with autism spectrum disorders. Neuropsychiatry, 3(4), 411–421. doi:10.2217/npy.13.53.
RUPP. (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The New England Journal of Medicine, 344(17), 1279–1285. doi:10.1056/NEJM200104263441703.
RUPP. (2002). The Pediatric Anxiety Rating Scale (PARS): Development and psychometric properties. Journal of the American Academy of Child and Adolescent Psychiatry, 41(9), 1061–1069. doi:10.1097/00004583-200209000-00006.
Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., et al. (1997). Children’s Yale-Brown Obsessive Compulsive Scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36(6), 844–852. doi:10.1097/00004583-199706000-00023.
Silverman, W. K., & Albano, A. M. (1996). The anxiety disorders interview schedule for DSM-IV–child and parent versions. London, England: Oxford University Press.
Steele, M., Jensen, P. S., & Quinn, D. M. (2006). Remission versus response as the goal of therapy in ADHD: A new standard for the field? Clinical Therapeutics, 28(11), 1892–1908. doi:10.1016/j.clinthera.2006.11.006.
Storch, E. A., Arnold, E. B., Lewin, A. B., Nadeau, J. M., Jones, A. M., De Nadai, A. S., et al. (2013). The effect of cognitive-behavioral therapy versus treatment as usual for anxiety in children with autism spectrum disorders: a randomized, controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry, 52(2), 132–142.e132, doi:10.1016/j.jaac.2012.11.007.
Storch, E. A., De Nadai, A. S., Lewin, A. B., McGuire, J. F., Jones, A. M., Mutch, P. J., et al. (2011). Defining treatment response in pediatric tic disorders: A signal detection analysis of the Yale Global Tic Severity Scale. Journal of Child and Adolescent Psychopharmacology, 21(6), 621–627. doi:10.1089/cap.2010.0149.
Storch, E. A., Ehrenreich-May, J., Wood, J. J., Jones, A. M., De Nadai, A. S., Lewin, A. B., et al. (2012a). Multiple informant agreement on the anxiety disorders interview schedule in youth with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 22(4), 292–299. doi:10.1089/cap.2011.0114.
Storch, E. A., Lewin, A. B., Collier, A. B., Arnold, E., De Nadai, A. S., Dane, B. F., et al. (2014). A randomized controlled trial of cognitive-behavioral therapy versus treatment as usual for adolescents with autism spectrum disorders and comorbid anxiety. Depression and Anxiety, 32(3), 174–181. doi:10.1002/da.22332.
Storch, E. A., Lewin, A. B., De Nadai, A. S., & Murphy, T. K. (2010). Defining treatment response and remission in obsessive–compulsive disorder: A signal detection analysis of the children’s yale-brown obsessive compulsive scale. Journal of the American Academy of Child and Adolescent Psychiatry, 49(7), 708–717. doi:10.1016/j.jaac.2010.04.005.
Storch, E. A., Wood, J. J., Ehrenreich-May, J., Jones, A. M., Park, J. M., Lewin, A. B., et al. (2012b). Convergent and discriminant validity and reliability of the pediatric anxiety rating scale in youth with autism spectrum disorders. Journal of Autism and Developmental Disorders, 42(11), 2374–2382. doi:10.1007/s10803-012-1489-9.
Sukhodolsky, D. G., Bloch, M. H., Panza, K. E., & Reichow, B. (2013). Cognitive-behavioral therapy for anxiety in children with high-functioning autism: A meta-analysis. [Meta Analysis]. Pediatrics, 132(5), e1341–e1350. doi:10.1542/peds.2013-1193.
Tolin, D. F., Abramowitz, J. S., & Diefenbach, G. J. (2005). Defining response in clinical trials for obsessive–compulsive disorder: A signal detection analysis of the Yale-Brown obsessive compulsive scale. Journal of Clinical Psychiatry, 66(12), 1549–1557.
Ung, D., Arnold, E., De Nadai, A., Lewin, A., Phares, V., Murphy, T., et al. (2014). Inter-rater reliability of the anxiety disorders interview schedule for DSM-IV in high-functioning youth with autism spectrum disorder. Journal of Developmental and Physical Disabilities, 26(1), 53–65. doi:10.1007/s10882-013-9343-3.
Vasa, R. A., Carroll, L. M., Nozzolillo, A. A., Mahajan, R., Mazurek, M. O., Bennett, A. E., et al. (2014). A Systematic Review of Treatments for Anxiety in Youth with Autism Spectrum Disorders. Journal of Autism and Developmental Disorders, 1–15, doi:10.1007/s10803-014-2184-9.
Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359(26), 2753–2766. doi:10.1056/NEJMoa0804633.
White, S. W., Ollendick, T., Albano, A. M., Oswald, D., Johnson, C., Southam-Gerow, M. A., et al. (2013). Randomized controlled trial: multimodal anxiety and social skill intervention for adolescents with autism spectrum disorder. Journal of Autism and Developmental Disorders, 43(2), 382–394. doi:10.1007/s10803-012-1577-x.
Williams, K., Wheeler, D. M., Silove, N., & Hazell, P. (2010). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Systematic Review, 8, CD004677. doi:10.1002/14651858.CD004677.pub2.
Wood, J. J., & Drahota, A. (2005). Behavioral interventions for anxiety in children with autism. Los Angeles, CA: University of California-Los Angeles.
Wood, J. J., Ehrenreich-May, J., Alessandri, M., Fujii, C., Renno, P., Laugeson, E., et al. (2015). Cognitive behavioral therapy for early adolescents with autism spectrum disorders and clinical anxiety: A randomized, controlled trial. Behavior Therapy, 46(1), 7–19. doi:10.1016/j.beth.2014.01.002.
Acknowledgments
This work was supported by a grant to the last author from the All Children’s Hospital Research Foundation, National Institute of Child Health and Development (1R34HD065274), and University of South Florida Internal Grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Child Health and Development or the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johnco, C.J., De Nadai, A.S., Lewin, A.B. et al. Defining Treatment Response and Symptom Remission for Anxiety Disorders in Pediatric Autism Spectrum Disorders Using the Pediatric Anxiety Rating Scale. J Autism Dev Disord 45, 3232–3242 (2015). https://doi.org/10.1007/s10803-015-2483-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-015-2483-9